1. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling;Alizadeh;Nature,2000
2. Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma;Berinstein;Ann Oncol,1998
3. Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets;Clynes;Nat Med,2000
4. Therapy of B-cell lymphoma with anti-CD20 antibodies can result in the loss of CD20 antigen expression;Davis;Clin Cancer Res,1999
5. Final report on the safety and efficacy of retreatment with rituximab for patients with non-Hodgkin's lymphoma;Davis;Blood,1999